Signature Estate & Investment Advisors LLC Decreases Stake in Amdocs Limited $DOX

Signature Estate & Investment Advisors LLC lowered its position in Amdocs Limited (NASDAQ:DOX) by 24.6% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 89,392 shares of the technology company’s stock after selling 29,144 shares during the period. Signature Estate & Investment Advisors LLC owned 0.08% of Amdocs worth $7,197,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Pzena Investment Management LLC lifted its holdings in Amdocs by 0.6% in the 3rd quarter. Pzena Investment Management LLC now owns 6,593,249 shares of the technology company’s stock valued at $540,976,000 after purchasing an additional 42,184 shares in the last quarter. LSV Asset Management lifted its holdings in Amdocs by 7.6% in the 3rd quarter. LSV Asset Management now owns 3,648,703 shares of the technology company’s stock valued at $299,376,000 after purchasing an additional 257,193 shares in the last quarter. Allspring Global Investments Holdings LLC lifted its holdings in Amdocs by 1.8% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 3,165,988 shares of the technology company’s stock valued at $253,786,000 after purchasing an additional 54,676 shares in the last quarter. Wellington Management Group LLP raised its holdings in shares of Amdocs by 3.0% during the 3rd quarter. Wellington Management Group LLP now owns 3,151,532 shares of the technology company’s stock worth $258,583,000 after acquiring an additional 91,900 shares during the period. Finally, Vanguard Group Inc. raised its holdings in shares of Amdocs by 0.3% during the 3rd quarter. Vanguard Group Inc. now owns 3,066,444 shares of the technology company’s stock worth $251,602,000 after acquiring an additional 9,207 shares during the period. Hedge funds and other institutional investors own 92.02% of the company’s stock.

Amdocs Stock Performance

Shares of Amdocs stock opened at $62.36 on Friday. The business has a 50-day simple moving average of $64.73 and a 200-day simple moving average of $72.87. The company has a market cap of $6.73 billion, a PE ratio of 12.47, a P/E/G ratio of 0.96 and a beta of 0.40. Amdocs Limited has a one year low of $59.40 and a one year high of $95.41. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.06 and a current ratio of 0.98.

Amdocs (NASDAQ:DOX) last posted its earnings results on Thursday, May 14th. The technology company reported $1.78 earnings per share for the quarter, topping the consensus estimate of $1.77 by $0.01. The firm had revenue of $1.17 billion during the quarter, compared to analysts’ expectations of $1.17 billion. Amdocs had a return on equity of 19.77% and a net margin of 11.81%.The firm’s revenue was up 3.9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.78 earnings per share. On average, equities research analysts forecast that Amdocs Limited will post 7.41 EPS for the current fiscal year.

Amdocs Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Tuesday, June 30th will be paid a $0.569 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $2.28 dividend on an annualized basis and a yield of 3.6%. Amdocs’s payout ratio is currently 45.60%.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on the company. Cfra lowered Amdocs to a “sell” rating in a report on Thursday, May 14th. Wall Street Zen lowered shares of Amdocs from a “buy” rating to a “hold” rating in a report on Saturday, May 16th. Barclays reduced their price objective on shares of Amdocs from $111.00 to $92.00 and set an “overweight” rating on the stock in a report on Wednesday, February 4th. Weiss Ratings restated a “hold (c-)” rating on shares of Amdocs in a report on Friday, May 8th. Finally, Stifel Nicolaus reduced their price objective on shares of Amdocs from $88.00 to $71.00 and set a “buy” rating on the stock in a report on Thursday, May 14th. Three equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $86.67.

Amdocs Company Profile

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.